scorecardresearch
Saturday, May 4, 2024
TopicUSFDA

Topic: USFDA

US FDA expands use of plasma therapy to treat Covid patients

The move will make it easier to receive the treatment, which Trump has promoted even though studies to prove its benefits haven’t been completed.

Pakistan has 1 lakh cases post lockdown, Sweden’s failed pandemic model & other Covid news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

US drug regulator approves use of diabetes drug, also sold in India, to prevent heart attack

The drug Farxiga is sold in India by UK-based pharma giant AstraZeneca under the brand name ‘Forxiga’ to treat type 2 diabetes.

US FDA says smokers could have higher risk of catching coronavirus

FDA had earlier said smokers may have worse outcomes from Covid-19, but hadn’t been explicit about whether that included chances of infection in the first place.

How the humble hydroxychloroquine has become India’s unlikely new global strategic asset

Donald Trump has labelled hydroxychloroquine a 'game-changer' in the fight against Covid-19. Indian pharma companies have gained significantly from this.

US FDA orders removal of ranitidine drugs from market over ‘carcinogen contamination’

Ranitidine is available in India under brand names of Aciloc and Zinetac but FDA specifically names Sanofi’s Zantac.

Torrent Pharma warned by US again, this time for using bacteria-contaminated water system

In the last 11 months, USFDA has issued 23 warning letters to Indian drugmakers. For Torrent Pharma, it's the third this year.

On Camera

Prajwal Revanna case shows why and how sexual crimes by men in politics can go unchecked for years

It would be a disservice to the women of Hassan to look at Prajwal Revanna’s alleged abuse of power as a ‘sex scandal’. Allegations against him show what ‘absolute power corrupts absolutely’ actually means.

Air India reduces baggage allowance by 5-15 kg, bringing it in line with rest of industry

Air India’s new policy, effective from 2 May, introduces new weight limits for tickets in each of the different 'fare families' — Comfort, Comfort Plus, and Flex.

China builds road through Shaksgam Valley, India registers protest

New Delhi has, in past, too, objected to Chinese construction activities in Shaksgam Valley. Work in this strategic region gathered pace after the 2017 Doklam stand-off.

Frontrunner is letting the challenger define this poll campaign. Modi still hasn’t found a big theme

A theme has not yet emerged for BJP & people see lack of a contest, which makes it unexciting. For all these reasons, 2024 is turning out to be an unexpectedly theme-less election.